Medizinische Universität Graz Austria/Österreich - Forschungsportal - Medical University of Graz
Publikationen
Suchbegriffe: MESOTHELIOMA, . Treffer: 72
2023
Brcic, L; Le, Stang, N; Gallob, F; Pissaloux, D; Sequeiros, R; Paindavoine, S; Pairon, JC; Karanian, M; Dacic, S; Girard, N; Churg, A; Tirode, F; Galateau-Salle, F
A Combination of MTAP and p16 Immunohistochemistry Can Substitute for CDKN2A Fluorescence In Situ Hybridization in Diagnosis and Prognosis of Pleural Mesotheliomas.
Arch Pathol Lab Med. 2023; 147(3):313-322
Doi: 10.5858/arpa.2021-0331-OA
Web of Science
PubMed
FullText
FullText_MUG
Liang, LB; Zhang, X; Ke, XX; Song, YX; Brcic, L; Neal, JW; Xu, G; Chen, C
Diagnosis and treatment of pericardial mesothelioma by mediastinal mass resection: a case report
ANN TRANSL MED. 2023;
Doi: 10.21037/atm-22-4719
Web of Science
FullText
FullText_MUG
Musoro, JZ; Coens, C; Sprangers, MAG; Brandberg, Y; Groenvold, M; Flechtner, HH; Cocks, K; Velikova, G; Dirven, L; Greimel, E; Singer, S; Pogoda, K; Gamper, EM; Sodergren, SC; Eggermont, A; Koller, M; Reijneveld, JC; Taphoorn, MJB; King, MT; Bottomley, A, , EORTC, Melanoma, Breast, Head, and, Neck, Genito-urinary, Gynecological, Gastro-intestinal, Brain, Lung, and, Quality, of, Life, Groups
Minimally important differences for interpreting EORTC QLQ-C30 change scores over time: A synthesis across 21 clinical trials involving nine different cancer types.
Eur J Cancer. 2023; 188:171-182
Doi: 10.1016/j.ejca.2023.04.027
PubMed
FullText
FullText_MUG
Pernthaler, B; Brcic, L; Aigner, RM; Fuchsjäger, M; Talakic, E
18F-FDG PET/CT in Primary Mesothelioma of the Liver.
Clin Nucl Med. 2023; 48(1): 49-51.
Doi: 10.1097/RLU.0000000000004445
Web of Science
PubMed
FullText
FullText_MUG
2022
Agaimy, A; Brcic, L; Briski, LM; Hung, YP; Michal, M; Michal, M; Nielsen, GP; Stoehr, R; Rosenberg, AE
NR4A3 fusions characterize a distinctive peritoneal mesothelial neoplasm of uncertain biological potential with pure adenomatoid/microcystic morphology.
Genes Chromosomes Cancer. 2022;
Doi: 10.1002/gcc.23118
Web of Science
PubMed
FullText
FullText_MUG
Gkika, E; Grosu, AL; Macarulla, Mercade, T; Cubillo, Gracián, A; Brunner, TB; Schultheiß, M; Pazgan-Simon, M; Seufferlein, T; Touchefeu, Y
Tumor Treating Fields Concomitant with Sorafenib in Advanced Hepatocellular Cancer: Results of the HEPANOVA Phase II Study.
Cancers (Basel). 2022; 14(6):
Doi: 10.3390/cancers14061568
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
Jurmeister, P; Leitheiser, M; Wolkenstein, P; Klauschen, F; Capper, D; Brcic, L
DNA methylation-based machine learning classification distinguishes pleural mesothelioma from chronic pleuritis, pleural carcinosis, and pleomorphic lung carcinomas.
Lung Cancer. 2022; 170:105-113
Doi: 10.1016/j.lungcan.2022.06.008
Web of Science
PubMed
FullText
FullText_MUG
Klebe, S; Galateau, Salle, F; Bruno, R; Brcic, L; I, Chen-Yost, H; Jaurand, MC
The highlights of the 15th international conference of the international mesothelioma interest group - Do molecular concepts challenge the traditional approach to pathological mesothelioma diagnosis?
Lung Cancer. 2022; 163:1-6
Doi: 10.1016/j.lungcan.2021.10.019
Web of Science
PubMed
FullText
FullText_MUG
Liang, L; Zhang, X; Ke, X; Song, Y; Brcic, L; Neal, JW; Xu, G; Chen, C
Diagnosis and treatment of pericardial mesothelioma by mediastinal mass resection: a case report.
Ann Transl Med. 2022; 10(24):1407
Doi: 10.21037/atm-22-4719
(- Case Report)
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
Mathilakathu, A; Wessolly, M; Mairinger, E; Uebner, H; Kreidt, D; Brcic, L; Steinborn, J; Greimelmaier, K; Wohlschlaeger, J; Schmid, KW; Mairinger, FD; Borchert, S
Cancer-Associated Fibroblasts Regulate Kinase Activity in Mesothelioma Cell Lines via Paracrine Signaling and Thereby Dictate Cell Faith and Behavior.
Int J Mol Sci. 2022; 23(6):
Doi: 10.3390/ijms23063278
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
Monaco, SE; Brcic, L; Dacic, S
State-of-the-art cytology of pleural fluid, focusing on the diagnosis of mesothelioma.
Cytopathology. 2022; 33(1):57-64
Doi: 10.1111/cyt.13055
Web of Science
PubMed
FullText
FullText_MUG
Rüschoff, JH; Haberecker, M; Tsourti, Z; Nackaerts, K; de, Perrot, M; Brcic, L; Nadal, E; Tsimpoukis, S; Gray, SG; Ampollini, L; Aerts, JG; Felley-Bosco, E; Kirschner, MB; Monkhorst, K; Weynand, B; Bavaghar-Zaeimi, F; Samarzija, M; Llatjos, R; Finn, SP; Silini, E; von, der, Thüsen, J; Marti, N; Vervita, K; Kammler, R; Peters, S; Stahel, RA; Baas, P; Opitz, I, , ETOP, Mesoscape, consortium
Expression of phosphorylated ribosomal protein S6 in mesothelioma patients - correlation with clinico-pathological characteristics and outcome: results from the European Thoracic Oncology Platform (ETOP) Mesoscape project.
Mod Pathol. 2022; 35(12):1888-1899
Doi: 10.1038/s41379-022-01145-0
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
2021
Absenger, G; Terbuch, A
Unresectable pleural mesothelioma-hope or still an unmet medical need?
MEMO-MAG EUR MED ONC. 2021;
Doi: 10.1007/s12254-021-00727-z
Web of Science
FullText
FullText_MUG
Brcic, L; Klikovits, T; Megyesfalvi, Z; Mosleh, B; Sinn, K; Hritcu, R; Laszlo, V; Cufer, T; Rozman, A; Kern, I; Mohorcic, K; Jakopovic, M; Samarzija, M; Seiwerth, S; Kolek, V; Fischer, O; Jakubec, P; Škarda, J; Gieszer, B; Hegedus, B; Fillinger, J; Renyi-Vamos, F; Buder, A; Bilecz, A; Berger, W; Grusch, M; Hoetzenecker, K; Klepetko, W; Hoda, MA; Filipits, M; Dome, B
Prognostic impact of PD-1 and PD-L1 expression in malignant pleural mesothelioma: an international multicenter study.
Transl Lung Cancer Res. 2021; 10(4): 1594-1607.
Doi: 10.21037/tlcr-20-1114
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
Brcic, L; Mathilakathu, A; Walter, RFH; Wessolly, M; Mairinger, E; Beckert, H; Kreidt, D; Steinborn, J; Hager, T; Christoph, DC; Kollmeier, J; Mairinger, T; Wohlschlaeger, J; Schmid, KW; Borchert, S; Mairinger, FD
Digital Gene Expression Analysis of Epithelioid and Sarcomatoid Mesothelioma Reveals Differences in Immunogenicity.
Cancers (Basel). 2021; 13(8):
Doi: 10.3390/cancers13081761
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
Chapel, DB; Schulte, JJ; Absenger, G; Attanoos, R; Brcic, L; Butnor, KJ; Chirieac, L; Churg, A; Galateau-Sallé, F; Hiroshima, K; Hung, YP; Kindler, H; Krausz, T; Marchevsky, A; Mino-Kenudson, M; Mueller, J; Nabeshima, K; Turaga, K; Walts, AE; Husain, AN
Malignant peritoneal mesothelioma: prognostic significance of clinical and pathologic parameters and validation of a nuclear-grading system in a multi-institutional series of 225 cases.
Mod Pathol. 2021; 34(2):380-395
Doi: 10.1038/s41379-020-00688-4
Web of Science
PubMed
FullText
FullText_MUG
Klebe, S; Nakatani, Y; Dobra, K; Butnor, KJ; Roden, AC; Nicholson, AG; Marchevsky, AM; Husain, AN; Segal, A; Walts, AE; Weynand, B; Michael, CW; Dacic, S; Godbolt, D; Attanoos, R; Santoni-Rugiu, E; Galateau-Salle, F; Hiroshima, K; Moreira, AL; Burn, J; Nabeshima, K; Gibbs, AR; Churg, A; Litzky, LA; Brcic, L; Tsao, MS; Mino-Kenudson, M; Rørvig, SB; Tazelaar, HD; Krausz, T; Zhang, YZ; Chirieac, LR; Beasley, MB; Hjerpe, A
The concept of mesothelioma in situ, with consideration of its potential impact on cytology diagnosis.
Pathology. 2021; 53(4):446-453
Doi: 10.1016/j.pathol.2020.12.005
Web of Science
PubMed
FullText
FullText_MUG
Mathilakathu, A; Borchert, S; Wessolly, M; Mairinger, E; Beckert, H; Steinborn, J; Hager, T; Christoph, DC; Kollmeier, J; Wohlschlaeger, J; Mairinger, T; Schmid, KW; Walter, RFH; Brcic, L; Mairinger, FD
Mitogen signal-associated pathways, energy metabolism regulation, and mediation of tumor immunogenicity play essential roles in the cellular response of malignant pleural mesotheliomas to platinum-based treatment: a retrospective study
TRANSL LUNG CANCER R. 2021;
Doi: 10.21037/tlcr-21-201
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
Opitz, I; Ruschoff, JH; Haberecker, M; Tsourti, Z; Nackaerts, K; Ampollini, L; De Perrot, M; Brcic, L; Nadal, E; Gray, S; Aerts, J; Verbeken, E; Silini, E; Zaeimi, F; Samarzija, M; Llatjos, R; Tsimpoukis, S; Von der Thusen, J; Finn, S; Monkhorst, K; Marti, N; Dimopoulou, G; Kammler, R; Peters, S; Baas, P; Stahel, R
Phosphorylated Ribosomal Protein S6, Correlation With Characteristics and Clinical Outcome in Patients With MPM: Results from ETOP Mesoscape
J THORAC ONCOL. Abstracts Book. 2021; 16(3):S152-S152.-IASLC 2020 World Conference on Lung Cancer; JAN 28-31, 2021; Virtuell.
[Poster]
Web of Science
Schulte, JJ; Chapel, DB; Attanoos, R; Brcic, L; Burn, J; Butnor, KJ; Chang, N; Chen, H; Dacic, S; De, Perrot, M; Fukuoka, J; Galateau-Salle, F; Godschachner, T; Hiroshima, K; Klebe, S; Krausz, T; Litzky, L; Marchevsky, AM; Mueller, J; Nabeshima, K; Nicholson, AG; Pal, P; Roden, AC; Rorvig, S; Santoni-Rugiu, E; Tazelaar, H; Tsao, MS; Walts, AE; Weynand, B; Zaizen, Y; Zhang, YZ; Husain, AN
Comparison of Nuclear Grade, Necrosis, and Histologic Subtype Between Biopsy and Resection in Pleural Malignant Mesothelioma: An International Multi-Institutional Analysis.
Am J Clin Pathol. 2021; 156(6):989-999
Doi: 10.1093/ajcp/aqab054
Web of Science
PubMed
FullText
FullText_MUG
2020
Bilecz, A; Stockhammer, P; Theegarten, D; Kern, I; Jakopovic, M; Samarzija, M; Klikovits, T; Hoda, MA; Döme, B; Oberndorfer, F; Muellauer, L; Fillinger, J; Kovács, I; Pirker, C; Schuler, M; Plönes, T; Aigner, C; Klepetko, W; Berger, W; Brcic, L; Laszlo, V; Hegedus, B
Comparative analysis of prognostic histopathologic parameters in subtypes of epithelioid pleural mesothelioma.
Histopathology. 2020;
Doi: 10.1111/his.14105
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
Brcic, L; Kern, I
Clinical significance of histologic subtyping of malignant pleural mesothelioma.
Transl Lung Cancer Res. 2020; 9(3): 924-933.
Doi: 10.21037/tlcr.2020.03.38
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
Galateau Salle, F; Le Stang, N; Tirode, F; Courtiol, P; Nicholson, AG; Tsao, MS; Tazelaar, HD; Churg, A; Dacic, S; Roggli, V; Pissaloux, D; Maussion, C; Moarii, M; Beasley, MB; Begueret, H; Chapel, DB; Copin, MC; Gibbs, AR; Klebe, S; Lantuejoul, S; Nabeshima, K; Vignaud, JM; Attanoos, R; Brcic, L; Capron, F; Chirieac, LR; Damiola, F; Sequeiros, R; Cazes, A; Damotte, D; Foulet, A; Giusiano-Courcambeck, S; Hiroshima, K; Hofman, V; Husain, AN; Kerr, K; Marchevsky, A; Paindavoine, S; Picquenot, JM; Rouquette, I; Sagan, C; Sauter, J; Thivolet, F; Brevet, M; Rouvier, P; Travis, WD; Planchard, G; Weynand, B; Clozel, T; Wainrib, G; Fernandez-Cuesta, L; Pairon, JC; Rusch, V; Girard, N
Comprehensive Molecular and Pathologic Evaluation of Transitional Mesothelioma Assisted by Deep Learning Approach: A Multi-Institutional Study of the International Mesothelioma Panel from the MESOPATH Reference Center.
J Thorac Oncol. 2020; 15(6):1037-1053
Doi: 10.1016/j.jtho.2020.01.025
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
Nicholson, AG; Sauter, JL; Nowak, AK; Kindler, HL; Gill, RR; Remy-Jardin, M; Armato, SG; Fernandez-Cuesta, L; Bueno, R; Alcala, N; Foll, M; Pass, H; Attanoos, R; Baas, P; Beasley, MB; Brcic, L; Butnor, KJ; Chirieac, LR; Churg, A; Courtiol, P; Dacic, S; De Perrot, M; Frauenfelder, T; Gibbs, A; Hirsch, FR; Hiroshima, K; Husain, A; Klebe, S; Lantuejoul, S; Moreira, A; Opitz, I; Perol, M; Roden, A; Roggli, V; Scherpereel, A; Tirode, F; Tazelaar, H; Travis, WD; Tsao, MS; van Schil, P; Vignaud, JM; Weynand, B; Lang-Lazdunski, L; Cree, I; Rusch, VW; Girard, N; Galateau-Salle, F
EURACAN/IASLC Proposals for Updating the Histologic Classification of Pleural Mesothelioma: Towards a More Multidisciplinary Approach.
J Thorac Oncol. 2020; 15(1):29-49
Doi: 10.1016/j.jtho.2019.08.2506
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
Pirker, C; Bilecz, A; Grusch, M; Mohr, T; Heidenreich, B; Laszlo, V; Stockhammer, P; Lötsch-Gojo, D; Gojo, J; Gabler, L; Spiegl-Kreinecker, S; Dome, B; Steindl, A; Klikovits, T; Hoda, MA; Jakopovic, M; Samarzija, M; Mohorcic, K; Kern, I; Kiesel, B; Brcic, L; Oberndorfer, F; Müllauer, L; Klepetko, W; Schmidt, WM; Kumar, R; Hegedus, B; Berger, W
Telomerase Reverse Transcriptase Promoter Mutations Identify a Genomically Defined and Highly Aggressive Human Pleural Mesothelioma Subgroup.
Clin Cancer Res. 2020; 26(14):3819-3830
Doi: 10.1158/1078-0432.CCR-19-3573
Web of Science
PubMed
FullText
FullText_MUG
Sadiku-Zehri, F; Gamulin, O; Škrabić, M; Qerimi-Krasniqi, A; Sedliž, F; Šepac, A; Brčić, L; Batelja Vuletić, L; Seiwerth, S
EXPRESS: Differentiating Between Malignant Mesothelioma and Other Pleural Lesions Using Fourier Transform Infrared Spectroscopy.
Appl Spectrosc. 2020; 3702820924726-3702820924726.
Doi: 10.1177/0003702820924726
Web of Science
PubMed
FullText
FullText_MUG
2019
Opitz, I; Bille, A; Tsourti, Z; Nakaerts, K; Ampollini, L; De Perrot, M; Brcic, L; Nadal, E; Gray, S; Aerts, J; Verbeken, E; Silini, E; Zaeimi, F; Samarzija, M; Llatjos, R; Tsimpoukis, S; van der Thusen, JH; Finn, S; Marti, N; Dimopoulou, G; Monkhorst, K; Brunello, A; Kammler, R; Soltermann, A; Falcoz, P; Baas, P; Stahel, R; Mesoscape, FE; Consortia, FE
Realtime Data from Europe ETOP / ESTS Database
J THORAC ONCOL. 2019; 14(10):S93-S94.-IASLC 2019 World Conference on Lung Cancer; SEP 7-10, 2019; Barcelona, SPAIN.
Doi: 10.1016/j.jtho.2019.08.210
[Oral Communication]
Web of Science
FullText
FullText_MUG
2018
Brcic, L; Vlacic, G; Quehenberger, F; Kern, I
Reproducibility of Malignant Pleural Mesothelioma Histopathologic Subtyping.
Arch Pathol Lab Med. 2018; 142(6):747-752
Doi: 10.5858/arpa.2017-0295-OA
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
Davidson, B; Pinamonti, M; Cuevas, D; Holth, A; Zeppa, P; Hager, T; Wohlschlaeger, J; Tötsch, M
The diagnostic role of PTEN and ARID1A in serous effusions.
Virchows Arch. 2018; 472(3):425-432
Doi: 10.1007/s00428-017-2273-1
Web of Science
PubMed
FullText
FullText_MUG
Davidson, B; Tötsch, M; Wohlschlaeger, J; Hager, T; Pinamonti, M
The diagnostic role of BAP1 in serous effusions.
Hum Pathol. 2018; 79(6):122-126
Doi: 10.1016/j.humpath.2018.05.012
Web of Science
PubMed
FullText
FullText_MUG
Mašić, S; Brčić, L; Krušlin, B; Šepac, A; Pigac, B; Stančić-Rokotov, D; Jakopović, M; Seiwerth, S
Expression of plakophilin 3 in diffuse malignant pleural mesothelioma.
Histol Histopathol. 2018; 103(7):11996-11996
Doi: 10.14670/HH-11-996
Web of Science
PubMed
FullText
FullText_MUG
Rosen, LE; Karrison, T; Ananthanarayanan, V; Gallan, AJ; Adusumilli, PS; Alchami, FS; Attanoos, R; Brcic, L; Butnor, KJ; Galateau-Sallé, F; Hiroshima, K; Kadota, K; Klampatsa, A; Stang, NL; Lindenmann, J; Litzky, LA; Marchevsky, A; Medeiros, F; Montero, MA; Moore, DA; Nabeshima, K; Pavlisko, EN; Roggli, VL; Sauter, JL; Sharma, A; Sheaff, M; Travis, WD; Vigneswaran, WT; Vrugt, B; Walts, AE; Tjota, MY; Krausz, T; Husain, AN
Nuclear grade and necrosis predict prognosis in malignant epithelioid pleural mesothelioma: a multi-institutional study.
Mod Pathol. 2018; 31(4):598-606
Doi: 10.1038/modpathol.2017.170
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
Schelch, K; Wagner, C; Hager, S; Pirker, C; Siess, K; Lang, E; Lin, R; Kirschner, MB; Mohr, T; Brcic, L; Marian, B; Holzmann, K; Grasl-Kraupp, B; Krupitza, G; Laszlo, V; Klikovits, T; Dome, B; Hegedus, B; Garay, T; Reid, G; van Zandwijk, N; Klepetko, W; Berger, W; Grusch, M; Hoda, MA
FGF2 and EGF induce epithelial-mesenchymal transition in malignant pleural mesothelioma cells via a MAPKinase/MMP1 signal.
Carcinogenesis. 2018; 39(4): 534-545.
Doi: 10.1093/carcin/bgy018
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
Walpole, S; Pritchard, AL; Cebulla, CM; Pilarski, R; Stautberg, M; Davidorf, FH; de la Fouchardière, A; Cabaret, O; Golmard, L; Stoppa-Lyonnet, D; Garfield, E; Njauw, CN; Cheung, M; Turunen, JA; Repo, P; Järvinen, RS; van Doorn, R; Jager, MJ; Luyten, GPM; Marinkovic, M; Chau, C; Potrony, M; Höiom, V; Helgadottir, H; Pastorino, L; Bruno, W; Andreotti, V; Dalmasso, B; Ciccarese, G; Queirolo, P; Mastracci, L; Wadt, K; Kiilgaard, JF; Speicher, MR; van Poppelen, N; Kilic, E; Al-Jamal, RT; Dianzani, I; Betti, M; Bergmann, C; Santagata, S; Dahiya, S; Taibjee, S; Burke, J; Poplawski, N; O'Shea, SJ; Newton-Bishop, J; Adlard, J; Adams, DJ; Lane, AM; Kim, I; Klebe, S; Racher, H; Harbour, JW; Nickerson, ML; Murali, R; Palmer, JM; Howlie, M; Symmons, J; Hamilton, H; Warrier, S; Glasson, W; Johansson, P; Robles-Espinoza, CD; Ossio, R; de Klein, A; Puig, S; Ghiorzo, P; Nielsen, M; Kivelä, TT; Tsao, H; Testa, JR; Gerami, P; Stern, MH; Paillerets, BB; Abdel-Rahman, MH; Hayward, NK
Comprehensive Study of the Clinical Phenotype of Germline BAP1 Variant-Carrying Families Worldwide.
JNCI-J NATL CANCER I. 2018; 110(12): 1328-1341.
Doi: 10.1093/jnci/djy171
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
2017
Arzt, L; Halbwedl, I; Gogg-Kamerer, M; Popper, HH
Signal Transducer and Activator of Transcription 1 (STAT1) Knock-down Induces Apoptosis in Malignant Pleural Mesothelioma.
Pathol Oncol Res. 2017; 23(3):595-605
Doi: 10.1007/s12253-016-0157-3
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
Dong, YW; Zhang, H; Schelch, K; Klikovits, T; Stockhammer, P; Jakopovic, M; Samarzija, M; Brcic, L; Reid, G; Kirschner, M; Kao, S; Opitz, I; Weder, W; Frauenfelder, T; Linh, NKTD; Klepetko, W; Van Zandwijk, N; Hegedus, B; Berger, W; Dome, B; Laszlo, V; Grusch, M; Hoda, M
Circulating Fibroblast Growth Factor 18 is Elevated in Malignant Pleural Mesothelioma Patients - A Multi-Institutional Study
J THORAC ONCOL. 2017; 12(1):S247-S248.-IASLC 17th World Conference on Lung Cancer; DEC 4-7, 2016; Vienna, AUSTRIA.
Doi: 10.1016/j.jtho.2016.11.234
[Oral Communication]
Web of Science
FullText
FullText_MUG
Hendry, S; Salgado, R; Gevaert, T; Russell, PA; John, T; Thapa, B; Christie, M; van de Vijver, K; Estrada, MV; Gonzalez-Ericsson, PI; Sanders, M; Solomon, B; Solinas, C; Van den Eynden, GGGM; Allory, Y; Preusser, M; Hainfellner, J; Pruneri, G; Vingiani, A; Demaria, S; Symmans, F; Nuciforo, P; Comerma, L; Thompson, EA; Lakhani, S; Kim, SR; Schnitt, S; Colpaert, C; Sotiriou, C; Scherer, SJ; Ignatiadis, M; Badve, S; Pierce, RH; Viale, G; Sirtaine, N; Penault-Llorca, F; Sugie, T; Fineberg, S; Paik, S; Srinivasan, A; Richardson, A; Wang, Y; Chmielik, E; Brock, J; Johnson, DB; Balko, J; Wienert, S; Bossuyt, V; Michiels, S; Ternes, N; Burchardi, N; Luen, SJ; Savas, P; Klauschen, F; Watson, PH; Nelson, BH; Criscitiello, C; O'Toole, S; Larsimont, D; de Wind, R; Curigliano, G; Andre, F; Lacroix-Triki, M; van de Vijver, M; Rojo, F; Floris, G; Bedri, S; Sparano, J; Rimm, D; Nielsen, T; Kos, Z; Hewitt, S; Singh, B; Farshid, G; Loibl, S; Allison, KH; Tung, N; Adams, S; Willard-Gallo, K; Horlings, HM; Gandhi, L; Moreira, A; Hirsch, F; Dieci, MV; Urbanowicz, M; Brcic, I; Korski, K; Gaire, F; Koeppen, H; Lo, A; Giltnane, J; Rebelatto, MC; Steele, KE; Zha, JP; Emancipator, K; Juco, JW; Denkert, C; Reis, J; Loi, S; Fox, SB
Assessing Tumor-Infiltrating Lymphocytes in Solid Tumors: A Practical Review for Pathologists and Proposal for a Standardized Method from the International Immuno-Oncology Biomarkers Working Group: Part 2: TILs in Melanoma, Gastrointestinal Tract Carcinomas, Non-Small Cell Lung Carcinoma and Mesothelioma, Endometrial and Ovarian Carcinomas, Squamous Cell Carcinoma of the Head and Neck, Genitourinary Carcinomas, and Primary Brain Tumors
ADV ANAT PATHOL. 2017; 24(6): 311-335.
Doi: 10.1097/PAP.0000000000000161
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
Mairinger, FD; Vollbrecht, C; Flom, E; Christoph, DC; Schmid, KW; Kollmeier, J; Popper, HH; Mairinger, T; Walter, RFH
Folic acid phenotype (FAP) is a superior biomarker predicting response to pemetrexed-based chemotherapy in malignant pleural mesothelioma.
Oncotarget. 2017; 8(23):37502-37510
Doi: 10.18632/oncotarget.16398
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
2016
Geltner, C; Errhalt, P; Baumgartner, B; Ambrosch, G; Machan, B; Eckmayr, J; Klikovits, T; Hoda, MA; Popper, H; Klepetko, W; Austrian Mesothelioma Interest Group (AMIG)
Management of malignant pleural mesothelioma - part 1: epidemiology, diagnosis, and staging : Consensus of the Austrian Mesothelioma Interest Group (AMIG).
Wien Klin Wochenschr. 2016; 128(17-18):611-617
Doi: 10.1007/s00508-016-1080-z
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
Hoda, MA; Dong, Y; Rozsas, A; Klikovits, T; Laszlo, V; Ghanim, B; Stockhammer, P; Ozsvar, J; Jakopovic, M; Samarzija, M; Brcic, L; Bendek, M; Szirtes, I; Reid, G; Kirschner, MB; Kao, SC; Opitz, I; Weder, W; Frauenfelder, T; Nguyen-Kim, TD; Aigner, C; Klepetko, W; van Zandwijk, N; Berger, W; Dome, B; Grusch, M; Hegedus, B
Circulating activin A is a novel prognostic biomarker in malignant pleural mesothelioma - A multi-institutional study.
Eur J Cancer. 2016; 63(1):64-73
Doi: 10.1016/j.ejca.2016.04.018
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
2015
Ghanim, B; Klikovits, T; Hoda, MA; Lang, G; Szirtes, I; Setinek, U; Rozsas, A; Renyi-Vamos, F; Laszlo, V; Grusch, M; Filipits, M; Scheed, A; Jakopovic, M; Samarzija, M; Brcic, L; Stancic-Rokotov, D; Kern, I; Rozman, A; Dekan, G; Klepetko, W; Berger, W; Glasz, T; Dome, B; Hegedus, B
Ki67 index is an independent prognostic factor in epithelioid but not in non-epithelioid malignant pleural mesothelioma: a multicenter study.
Br J Cancer. 2015; 112(5): 783-792.
Doi: 10.1038/bjc.2015.9
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
Laszlo, V; Hoda, MA; Garay, T; Pirker, C; Ghanim, B; Klikovits, T; Dong, YW; Rozsas, A; Kenessey, I; Szirtes, I; Grusch, M; Jakopovic, M; Samarzija, M; Brcic, L; Kern, I; Rozman, A; Popper, H; Zöchbauer-Müller, S; Heller, G; Altenberger, C; Ziegler, B; Klepetko, W; Berger, W; Dome, B; Hegedus, B
Epigenetic down-regulation of integrin α7 increases migratory potential and confers poor prognosis in malignant pleural mesothelioma.
J Pathol. 2015; 237(2):203-214
Doi: 10.1002/path.4567
Web of Science
PubMed
FullText
FullText_MUG
2014
Arzt, L; Kothmaier, H; Halbwedl, I; Quehenberger, F; Popper, HH
Signal transducer and activator of transcription 1 (STAT1) acts like an oncogene in malignant pleural mesothelioma.
Virchows Arch. 2014; 465(1):79-88
Doi: 10.1007/s00428-014-1584-8
Web of Science
PubMed
FullText
FullText_MUG
Arzt, L; Quehenberger, F; Halbwedl, I; Mairinger, T; Popper, HH
BAP1 protein is a progression factor in malignant pleural mesothelioma.
Pathol Oncol Res. 2014; 20(1):145-151
Doi: 10.1007/s12253-013-9677-2
Web of Science
PubMed
FullText
FullText_MUG
Brčić, L; Jakopović, M; Brčić, I; Klarić, V; Milošević, M; Sepac, A; Samaržija, M; Seiwerth, S
Reproducibility of histological subtyping of malignant pleural mesothelioma.
Virchows Arch. 2014; 465(6): 679-685.
Doi: 10.1007/s00428-014-1664-9
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
Ghanim, B; Hoda, MA; Klikovits, T; Winter, MP; Alimohammadi, A; Grusch, M; Dome, B; Arns, M; Schenk, P; Jakopovic, M; Samarzija, M; Brcic, L; Filipits, M; Laszlo, V; Klepetko, W; Berger, W; Hegedus, B
Circulating fibrinogen is a prognostic and predictive biomarker in malignant pleural mesothelioma.
Br J Cancer. 2014; 110(4): 984-990.
Doi: 10.1038/bjc.2013.815
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
Schelch, K; Hoda, MA; Klikovits, T; Münzker, J; Ghanim, B; Wagner, C; Garay, T; Laszlo, V; Setinek, U; Dome, B; Filipits, M; Pirker, C; Heffeter, P; Selzer, E; Tovari, J; Torok, S; Kenessey, I; Holzmann, K; Grasl-Kraupp, B; Marian, B; Klepetko, W; Berger, W; Hegedus, B; Grusch, M
Fibroblast growth factor receptor inhibition is active against mesothelioma and synergizes with radio- and chemotherapy.
Am J Respir Crit Care Med. 2014; 190(7):763-772
Doi: 10.1164/rccm.201404-0658OC
Web of Science
PubMed
FullText
FullText_MUG
2013
Lindenmann, J; Matzi, V; Neuboeck, N; Anegg, U; Maier, A; Smolle, J; Smolle-Juettner, FM
Multimodal therapy of malignant pleural mesothelioma: is the replacement of radical surgery imminent?
Interact Cardiovasc Thorac Surg. 2013; 16(3):237-243
Doi: 10.1093/icvts/ivs465
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
Mairinger, F; Vollbrecht, C; Halbwedl, I; Hatz, M; Stacher, E; Gülly, C; Quehenberger, F; Stephan-Falkenau, S; Kollmeier, J; Roth, A; Mairinger, T; Popper, H
Reduced folate carrier and folylpolyglutamate synthetase, but not thymidylate synthase predict survival in pemetrexed-treated patients suffering from malignant pleural mesothelioma.
J Thorac Oncol. 2013; 8(5):644-653
Doi: 10.1097/JTO.0b013e318287c224
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
Murali, R; Wiesner, T; Scolyer, RA
Tumours associated with BAP1 mutations.
Pathology. 2013; 45(2):116-126
Doi: 10.1097/PAT.0b013e32835d0efb
Web of Science
PubMed
FullText
FullText_MUG
Weitere 50 Treffer anzeigen